Biotech

All Articles

Fierce Biotech's Gabrielle Masson shows Tough 15 at NYSE

.Brutal Biotech Associate Publisher Gabrielle Masson presented the 2024 class of Brutal 15 champions...

Novo Nordisk centers once-monthly GLP-1\/ GIP agonist, MASH possibility

.Novo Nordisk has axed its once-monthly dual GLP-1/ GIP receptor agonist, ending (PDF) advancement o...

Daiichi pays for Merck $170M to form bronchi cancer T-cell engager deal

.Merck &amp Co. has actually quickly redeemed a few of the prices of its own Weapon Therapies purcha...

BioMarin standstills preclinical gene therapy for heart condition

.After BioMarin conducted a springtime clean of its own pipeline in April, the business has actually...

Eisai plants molecular adhesive SEED with $1.5 B biobucks work

.Major Pharmas continue to be stuck to the concept of molecular glue degraders. The current business...

Life scientific research credit organization reveals along with $600M

.A brand-new worldwide lifestyle science credit score agency, termed Symbiotic Resources, has actual...

BMS channels TIGIT, ignoring $200M bank on Agenus bispecific

.Bristol Myers Squibb is actually axing an additional big bet coming from the Caforio period, termin...

Nuvation stops BET inhibitor after thinking about phase 1 data

.After having a look at phase 1 data, Nuvation Biography has actually decided to halt work on its on...

' Professional intuitiveness' led FDA specialists to support Zevra's uncommon disease med

.Zevra Therapies' unusual ailment medication seems to be on the pathway to approval this autumn afte...

Pfizer takes $230M attacked after axing fell short DMD genetics treatment

.Pfizer's stage 3 Duchenne muscle dystrophy (DMD) genetics therapy failure has actually blown a $230...